ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #17,432Hybrid

Journal of Labelled Compounds & Radiopharmaceuticals

Acronym:jlcr
•
Abbreviation (ISO):J LABELLED COMPD RAD
•
Identifier (ISSN):0362-4803(Print)/1099-1344(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
1.3↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Labelled Compounds & Radiopharmaceuticals

WoS Q4
01231.4220181.2920191.9220211.9520221.820230.920240.920251.32026
Annual Impact Factor Metric
Current (2026):1.3
Scopus SJR & RankScopus Q3
0.293
#17,432

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
58

58 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
30articles/year
32.23% Gold OA•100% Original Research

Aims & Scope

The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.

Topics Covered (Recognized by AI)
Chemistry99.1%Biology69.3%Organic chemistry62.6%Biochemistry61.5%Physics52.9%Medicine41%Genetics39.1%Stereochemistry36.1%Materials science34.6%Radiochemistry32%Internal medicine30%Quantum mechanics29.9%Metallurgy27.5%Medicinal chemistry24.5%Nuclear physics24.1%Composite material22.3%Catalysis21.8%Psychology20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMICAL RESEARCH METHODS

Q4
Rank80/85
IndexSCIE
JCRSCIE2026

CHEMISTRY, ANALYTICAL

Q4
Rank95/110
IndexSCIE
JCRSCIE2026

CHEMISTRY, MEDICINAL

Q4
Rank66/72
IndexSCIE
JCISCIE2026

BIOCHEMICAL RESEARCH METHODS

Q4
Rank83/85
IndexSCIE
JCISCIE2026

CHEMISTRY, ANALYTICAL

Q4
Rank101/110
IndexSCIE
JCISCIE2026

CHEMISTRY, MEDICINAL

Q4
Rank67/72
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.3
Articles / Year33
Total Citations3
2025
IF0.9
Articles / Year62
Total Citations30
2024
IF0.9
Articles / Year59
Total Citations54
2023
IF1.8
Articles / Year77
Total Citations235
2022
IF1.949
Articles / Year63
Total Citations137

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,432Scopus Q3SCImago Profile
Scopus Coverage:1976-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemistryMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.293

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.29

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,757 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations151
3-Year Documents128
Citable Documents121

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate28.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Analytical ChemistryQ3
Drug DiscoveryQ3
Organic ChemistryQ3
Radiology, Nuclear Medicine and ImagingQ3
SpectroscopyQ3
BiochemistryQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区BIOCHEMICAL RESEARCH METHODS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Labelled Compounds & Radiopharmaceuticals (acronym: jlcr, abbr: J LABELLED COMPD RAD, ISSN: 0362-4803) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Ltd in England since 1976. The periodical holds a Journal Impact Factor (JIF) of 1.30, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.293 (Q3), an H-index of 58.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 30 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,757 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Ltd
Publication Language
Multi-Language
Frequency
Monthly
Founding Year
1976
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6b682eb6-8fb8-40ee-872b-98d2f7cad1ed
Database Updated: 2026-09-29